NM_006412.4:c.299G>A
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_006412.4(AGPAT2):c.299G>A(p.Ser100Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. S100S) has been classified as Likely benign.
Frequency
Consequence
NM_006412.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital generalized lipodystrophy type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal diabetes mellitusInheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGPAT2 | NM_006412.4 | c.299G>A | p.Ser100Asn | missense_variant | Exon 2 of 6 | ENST00000371696.7 | NP_006403.2 | |
| AGPAT2 | NM_001012727.2 | c.299G>A | p.Ser100Asn | missense_variant | Exon 2 of 5 | NP_001012745.1 | ||
| AGPAT2 | XM_047422636.1 | c.-11G>A | 5_prime_UTR_variant | Exon 2 of 6 | XP_047278592.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGPAT2 | ENST00000371696.7 | c.299G>A | p.Ser100Asn | missense_variant | Exon 2 of 6 | 1 | NM_006412.4 | ENSP00000360761.2 | ||
| AGPAT2 | ENST00000371694.7 | c.299G>A | p.Ser100Asn | missense_variant | Exon 2 of 5 | 1 | ENSP00000360759.3 | |||
| AGPAT2 | ENST00000470861.1 | n.307G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
| AGPAT2 | ENST00000472820.1 | n.-60G>A | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152262Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000800 AC: 2AN: 250022 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460888Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 726752 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74392 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital generalized lipodystrophy type 1 Pathogenic:1Other:1
Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by extreme reduction of white adipose tissue (WAT) mass. CGL type 1 is the most frequent form and is caused by mutations in AGPAT2. Genetic and clinical studies were performed in two affected sisters of a Chilean family. These patients have notoriously dissimilar metabolic abnormalities that correlate with differential levels of circulating leptin and soluble leptin receptor fraction. Sequencing of AGPAT2 exons and exon-intron boundaries revealed two homozygous mutations in both sisters. Missense mutation c.299G>A changes a conserved serine in the acyltransferase NHX4D motif of AGPAT2 (p.Ser100Asn). In silico protein modeling provided insights of the mechanisms of lack of catalytic activity owing to both mutations.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at